Polycythemia vera is a myeloproliferative disorder featuring an abnormal proliferation of erythroid, megakaryocytic and myeloid elements with an increased red cell mass, not secondary to hypoxemia. The criteria of the Polycythemia Vera Study Group is intended to identify patients with polycythemia vera in order to compare different therapeutic interventions.